CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 3 filers reported holding CTI BIOPHARMA CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,365,246 | -13.0% | 1,753,630 | +24.5% | 1.60% | -28.9% |
| Q4 2022 | $8,465,938 | +20.2% | 1,408,642 | +16.4% | 2.25% | +12.6% |
| Q3 2022 | $7,043,000 | +12.2% | 1,210,145 | +15.1% | 2.00% | -13.4% |
| Q2 2022 | $6,275,000 | +497.1% | 1,051,047 | +367.1% | 2.31% | +650.3% |
| Q1 2022 | $1,051,000 | – | 225,000 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,800,358 | $21,825,000 | 10.02% |
| CAXTON CORP | 2,239,300 | $5,553,000 | 4.54% |
| Altium Capital Management LP | 2,185,000 | $5,419,000 | 1.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,483,829 | $3,680,000 | 1.49% |
| Ghost Tree Capital, LLC | 1,200,000 | $2,976,000 | 1.07% |
| Lion Point Capital, LP | 1,223,595 | $3,034,000 | 0.81% |
| BVF INC/IL | 8,929,690 | $22,146,000 | 0.80% |
| NEA Management Company, LLC | 7,140,450 | $17,708,000 | 0.36% |
| Knott David M Jr | 221,079 | $548,000 | 0.19% |
| Lakeside Advisors, INC. | 97,780 | $242,000 | 0.18% |